
Grace P Makari-Judson MD
Breast Cancer, Cancer Genetics/Cancer Risk Assessment
Professor of Medicine, University of Massachusetts Medical School-Baystate
Join to view full profile
3350 Main StSpringfield, MA 01107
Phone+1 413-794-9338
Fax+1 413-794-9754
Dr. Makari-Judson is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Hematology and Medical Oncology, 1985 - 1988
New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1982 - 1985
Weill Cornell MedicineClass of 1982
Certifications & Licensure
NY State Medical License 1983 - Present
MA State Medical License 1988 - 2027
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification FairWarning® Patient Privacy Monitoring, FairWarning Technologies, LLC, 2011, 2013-2014
- CMS Meaningful Use Stage 1 Certification HealthShare, InterSystems Corp., 2011, 2013-2014
- CMS Meaningful Use Stage 1 Certification HealthSentry, Cerner Corporation, 2011, 2013-2014
Clinical Trials
Publications & Presentations
PubMed
- The Experiences and Needs of Individuals with a Variant of Uncertain Significance on Genetic Tests for Hereditary Cancer Syndromes:A Grounded Theory Study.Danielle Gould, Rae Walker, Grace Makari-Judson, Memnun Seven
Seminars in Oncology Nursing. 2026-04-01 - 4 citationsAlternating 17β-Estradiol and Aromatase Inhibitor Therapies Is Efficacious in Postmenopausal Women with Advanced Endocrine-Resistant ER+ Breast Cancer.Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar, Jonathan D Marotti, Mary D Chamberlin
Clinical Cancer Research. 2023-08-01 - Alternating 17beta-estradiol and aromatase inhibitor therapies is efficacious in post-menopausal women with advanced endocrine-resistant ER+ breast cancer.Gary N Schwartz, Peter A Kaufman, Karthik V Giridhar, Jonathan D Marotti, Mary D Chamberlin
Clinical Cancer Research. 2023-05-15
Press Mentions
Breast Cancer Risk Factors for Women Under 45 Years OldOctober 5th, 2022
Clinical Breast Exam May Not Be Needed for Follow-UpJuly 1st, 2022
Rays of Hope Marks 25th Year in Battle Against Breast CancerOctober 3rd, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









